Treatment of UTI with Proteus mirabilis and Enterococcus faecalis
For a urinary tract infection with both Proteus mirabilis and Enterococcus faecalis, gentamicin should be added to Augmentin (amoxicillin/clavulanate) for optimal treatment, as it provides synergistic coverage against Enterococcus while Augmentin effectively treats the Proteus infection.
Rationale for Combination Therapy
- Augmentin (amoxicillin/clavulanate) alone is effective against Proteus mirabilis but may benefit from additional coverage for Enterococcus faecalis in complicated or polymicrobial infections 1, 2
- Gentamicin provides synergistic activity against Enterococcus faecalis when combined with beta-lactams like amoxicillin (contained in Augmentin) 1
- This combination therapy approach is supported by guidelines for treating infections with these specific organisms, particularly when both are present simultaneously 1
Antimicrobial Selection Considerations
For Proteus mirabilis:
- Proteus mirabilis in this case is susceptible to Augmentin, which is already part of the treatment plan 2, 3
- Augmentin effectively treats amoxicillin-resistant strains of Proteus due to the beta-lactamase inhibitor (clavulanic acid) component 4
- Recent evidence supports Augmentin's effectiveness against resistant Enterobacterales in urinary tract infections 5
For Enterococcus faecalis:
- Enterococcus faecalis is susceptible to ampicillin (similar to amoxicillin in Augmentin) but benefits from synergistic therapy 1
- Guidelines recommend the addition of an aminoglycoside (like gentamicin) to a beta-lactam for enhanced bactericidal activity against Enterococcus 1
- Gentamicin at 3 mg/kg/day IV or IM in a single daily dose provides optimal synergy with the beta-lactam component of Augmentin 1
Dosing Recommendations
- Augmentin: Continue at standard dosing (typically 875 mg PO twice daily) 1, 2
- Add gentamicin: 3-5 mg/kg/day IV or IM as a single daily dose 1
- Duration of therapy: 5-7 days for uncomplicated UTI; 10-14 days for complicated UTI 1
Important Clinical Considerations
- Monitor renal function and gentamicin levels, particularly with extended therapy 1
- Consider local resistance patterns when finalizing therapy choices 1
- If gentamicin cannot be used due to contraindications, alternative options include:
Common Pitfalls to Avoid
- Treating only one organism in polymicrobial infections can lead to treatment failure 1
- Underestimating the need for synergistic therapy against Enterococcus faecalis 1
- Failing to monitor for aminoglycoside toxicity with prolonged therapy 1
- Not adjusting therapy based on clinical response and susceptibility results 1
By adding gentamicin to Augmentin, you provide comprehensive coverage for both organisms with synergistic activity against Enterococcus faecalis while maintaining effective treatment for Proteus mirabilis.